Purdue Opposes Requests To Delay Ch. 11 Plan For Appeals
Purdue Pharma LP is arguing that delaying the consummation of its Chapter 11 plan to allow appeals to be resolved first would needlessly delay the distribution of billions of dollars for...To view the full article, register now.
Already a subscriber? Click here to view full article